BioMarin and n-Lorem Foundation Enter Early Research Collaboration to Develop Potential First-in-Disease Medicine for Newly Identified ReNU Syndrome
ReNU syndrome was discovered [...]
Servier and n-Lorem Foundation Join Forces to Advance Research in Rare Neurodevelopmental Disorders
Partnership will combine n-Lorem's cutting-edge [...]
New Publication Provides an Unprecedented Look at the Largest Reported Cohort of Nano-Rare Patients Evaluated for Individualized ASO Therapies
First-of-its-kind perspective from the [...]
n-Lorem Foundation Announces the 50th Nano-rare Patient Receives Personalized ASO Medicine
Physicians collaborating with [...]
n-Lorem Publishes Commentary Offering Insight into Potential Commercialization Strategies for Nano-rare Medicines
The commentary titled ‘Establishing [...]
n-Lorem and EspeRare announce European collaboration to expand access to individualized ASO Therapies for Rare Genetic Diseases
SAN DIEGO, California and GENEVA, [...]
n-Lorem Foundation Publishes Study Showing Targeted ASO Therapy Restores GBE1 Protein in APBD Patient Cells
Research, published in Nucleic [...]
